Category: United States
-
CAT opens new fronts in Doosan dispute with USITC, District of Delaware complaints
The latest filings come in response to Doosan Bobcat’s previous infringement actions in the U.S. and Europe.
-
Federal Circuit affirms district judge’s overruling of $469M jury verdict against DISH Network
ClearPlay sued DISH Network over its TV ad-skipping feature back in 2014, alleging infringement of two patents.
-
Power provider AES and partner Fluence targeted by non-practicing entity over patents relevant to clean energy distribution, storage
GridScale Solutions LLC has sued the two companies in the U.S. District Court for the Eastern District of Virginia.
-
USPTO denies ex parte reexam following earlier “settled expectations” refusal of inter partes review; Director defends discretionary powers before Federal Circuit
Geotab previously had its petition for IPR denied, at least on a partial basis of patent owner Fractus having settled expectations as per validity.
-
Samsung leads U.S. AI patent grants 2025, otherwise largely dominated by Big Tech
Meanwhile, 12 of the top 100 U.S. AI patent holders are automakers, meaning AI is becoming front and center of the car manufacturing industry, a report by Harrity Patent Analytics has revealed.
-
ByteDance faces litigation on multiple fronts from Dominion Harbor entities asserting SEPs and non-SEPs
Lark, ByteDance’s workplace collaboration platform, has been targeted; while TikTok and virtual reality gear maker Pico have also been sued.
-
Federal Circuit says owners of patents subject to exclusive license still have standing to sue where terms don’t render rights “illusory”
A.L.M. and Ergon granted wide-ranging rights to an exclusive licensee – but retained the right to sue third-party infringers.
-
Pharma giant Takeda ordered to pay over $884 million in damages in Amitiza class action suit: patent litigation settlement was anticompetitive, jury finds
Takeda has said it already plans to “vigorously” appeal the decision, which found its 2014 deal with competitor Par Pharmaceutical to drop its challenge to its AMITIZA patents and delay its generic entry by seven years, anticompetitive.
-
Malikie Innovations sues TCL over Wi-Fi, AV1 patents in Eastern District of Texas, hints at future request for injunction
Malikie Innovations claims that TCL has not acted in “good faith” when it comes to FRAND negotiations.